by Vandana Singh | Oct 7, 2026 | General
The U.S. Food and Drug Administration (FDA) on Wednesday approved Pfizer Inc.’s (NYSE:PFE) TUKYSA (tucatinib) in combination with trastuzumab and pertuzumab. This regimen serves as a maintenance therapy for adults battling unresectable locally advanced or metastatic...
by Khyathi Dalal | Oct 7, 2026 | General
Bitcoin broke below $84,000 support Wednesday as Treasury yields surged to 24-year highs.CryptocurrencyTickerPriceBitcoin(CRYPTO: BTC)$83,332.93Ethereum(CRYPTO: ETH)$2,558.02Solana(CRYPTO: SOL)$116.70XRP(CRYPTO: XRP)$1.42Dogecoin(CRYPTO: DOGE)$0.0885Shiba Inu(CRYPTO:...
by Lekha Gupta | Oct 7, 2026 | General
CoreWeave, Inc. (NASDAQ:CRWV) stock is trading lower by about 4% on Wednesday as investors retreat from growth-focused technology stocks amid broader market weakness and rising Treasury yields ahead of the September FOMC minutes.The Nasdaq is down 0.32%, while the...
by Daragh Thomas | Oct 7, 2026 | General
Meta Platforms Inc. (NASDAQ:META) and two Alphabet Inc. (NASDAQ:GOOGL) units, Google DeepMind and Isomorphic Labs, are jointly putting $300 million into a Mark Zuckerberg-backed effort to build AI models that can predict how living cells behave. The investment expands...
by Evette Mitkov | Oct 7, 2026 | General
Intel Corp (NASDAQ:INTC) shares are trending Wednesday. CEO Lip-Bu Tan said the company will remain a part of Elon Musk’s Terafab project. Intel stock is showing upward bias. What should traders watch with INTC? Intel Stock Trends After Lip-Bu Tan Confirms Terafab...
Recent Comments